Real-world analysis of treatments, healthcare costs, and overall survival among patients with metastatic non-small cell lung cancer by molecular biomarker testing approach
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Real-world analysis of treatments, healthcare costs, and overall survival among patients with metastatic non-small cell lung cancer by molecular biomarker testing approach. // Cancer Treatment and Research Communications. – URL: https://www.sciencedirect.com/science/article/pii/S2468294226003886?dgcid=rss_sd_all
Real-world analysis of treatments, healthcare costs, and overall survival among patients with metastatic non-small cell lung cancer by molecular biomarker testing approach. Cancer Treatment and Research Communications. https://www.sciencedirect.com/science/article/pii/S2468294226003886?dgcid=rss_sd_all
“Real-world analysis of treatments, healthcare costs, and overall survival among patients with metastatic non-small cell lung cancer by molecular biomarker testing approach.” Cancer Treatment and Research Communications.
@article{article93543,
title = {Real-world analysis of treatments, healthcare costs, and overall survival among patients with metastatic non-small cell lung cancer by molecular biomarker testing approach},
journal = {Cancer Treatment and Research Communications},
url = {https://www.sciencedirect.com/science/article/pii/S2468294226003886?dgcid=rss_sd_all}
}